financetom
Business
financetom
/
Business
/
CSG Systems Q4 Non-GAAP Earnings, Revenue Increase -- Shares Rise After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CSG Systems Q4 Non-GAAP Earnings, Revenue Increase -- Shares Rise After Hours
Feb 5, 2025 2:51 PM

05:33 PM EST, 02/05/2025 (MT Newswires) -- CSG Systems International ( CSGS ) reported Q4 non-GAAP earnings late Wednesday of $1.65 per share, up from $0.92 a year earlier.

Analysts polled by FactSet expected $1.21.

Revenue for the quarter ended Dec. 31 was $316.7 million, up from $297.3 million.

Analysts surveyed by FactSet expected $312.9 million.

The company said it expects full-year 2025 non-GAAP earnings of $4.55 to $4.80 per share on revenue of $1.21 billion to $1.25 billion.

Analysts polled by FactSet expect $4.54 on revenue of $1.22 billion.

Meanwhile, the company said its board approved a 7% increase in its quarterly dividend to $0.32 per share.

The new dividend is payable on April 2 to shareholders of record on March 19.

Shares of CSG Systems International ( CSGS ) were up 5% in after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arrowhead Files Plozasiran New Drug Application in Familial Chylomicronemia Syndrome
Arrowhead Files Plozasiran New Drug Application in Familial Chylomicronemia Syndrome
Nov 19, 2024
08:41 AM EST, 11/18/2024 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said Monday that it submitted a new drug application to the US Food and Drug Administration for its experimental drug, plozasiran, to treat familial chylomicronemia syndrome, a rare disease that could lead to potentially fatal pancreatitis. The company said the application is supported by data from a phase...
Bausch Health Canada Receives Reimbursement Recommendation for Acne Treatment
Bausch Health Canada Receives Reimbursement Recommendation for Acne Treatment
Nov 19, 2024
08:45 AM EST, 11/18/2024 (MT Newswires) -- Bausch Health's ( BHC ) Canada subsidiary said Monday Canada's Drug Agency and Quebec's Institut national d'excellence en sante et en services sociaux have given positive reimbursement recommendations for its drug Cabtreo as a treatment for acne vulgaris in patients 12 years of age and older. The recommendations are a step in the...
Koryx Copper Appointed Heye Daun As President & CEO, Trevor Faber As COO
Koryx Copper Appointed Heye Daun As President & CEO, Trevor Faber As COO
Nov 19, 2024
08:45 AM EST, 11/18/2024 (MT Newswires) -- Koryx Copper ( KRYXF ) , which lost 5.6% last Friday, on Monday appointed Heye Daun as President and Chief Executive Officer and Trevor Faber as Chief Operating Officer. It said Heye Daun will also retain his board position as Chairman and Pierre Leveille steps down as President and remains on the Board...
Old Dominion Freight Line to Implement General Rate Increase
Old Dominion Freight Line to Implement General Rate Increase
Nov 19, 2024
08:39 AM EST, 11/18/2024 (MT Newswires) -- Old Dominion Freight Line ( ODFL ) said Monday it will implement a general rate increase of 4.9% applicable to its 559, 670 and 550 tariffs, starting Dec. 2. The increase is intended to partially offset the rising costs of real estate, new equipment, technology investments, and competitive employee wage and benefit packages,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved